| Name | Aurora Pharmacy Inc |
|---|---|
| Organization Name | Aurora Pharmacy Inc |
| Location | 1881 Chicago St, De Pere, Wisconsin 54115 |
| Type | Pharmacy |
| Phone | (920) 403-8050 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production.
By comparing vaccination rates in 580 counties across the United States with the corresponding coronavirus disease (COVID-19) incidence rates, a recent study currently available on the medRxiv preprint server finds that cumulative county-level vaccination rates are significantly associated with a concomitant fall in the incidence of COVID-19.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
IRIDEX Corporation, today announced the commencement of commercial shipment of the IQ 532 laser systems. The IQ 532 is a high-power, 532 nm, dual port multi-purpose laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma; and for use by otolaryngologists to correct certain types of conductive hearing loss.
› Verified 1 days ago
| NPI Number | 1255365474 |
| Organization Name | AURORA PHARMACY INC |
| Doing Business As | AURORA PHARMACY |
| Type | Pharmacy |
| Address | 1881 Chicago St, De Pere, WI 54115 |
| Phone Number | 920-403-8050 |
News Archive
A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production.
By comparing vaccination rates in 580 counties across the United States with the corresponding coronavirus disease (COVID-19) incidence rates, a recent study currently available on the medRxiv preprint server finds that cumulative county-level vaccination rates are significantly associated with a concomitant fall in the incidence of COVID-19.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
IRIDEX Corporation, today announced the commencement of commercial shipment of the IQ 532 laser systems. The IQ 532 is a high-power, 532 nm, dual port multi-purpose laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma; and for use by otolaryngologists to correct certain types of conductive hearing loss.
› Verified 1 days ago
News Archive
A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production.
By comparing vaccination rates in 580 counties across the United States with the corresponding coronavirus disease (COVID-19) incidence rates, a recent study currently available on the medRxiv preprint server finds that cumulative county-level vaccination rates are significantly associated with a concomitant fall in the incidence of COVID-19.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
IRIDEX Corporation, today announced the commencement of commercial shipment of the IQ 532 laser systems. The IQ 532 is a high-power, 532 nm, dual port multi-purpose laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma; and for use by otolaryngologists to correct certain types of conductive hearing loss.
› Verified 1 days ago
Aurora Pharmacy Inc Type: Pharmacy Location: 1881 Chicago St, De Pere, Wisconsin 54115 Phone: (920) 403-8050 | |
Depere Hometown Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 510 Redbird Cir, De Pere, Wisconsin 54115 Phone: (920) 351-8155 | |
Eye And Vision Clinics Sc Type: Medicare Supplier Location: 301 N Broadway, De Pere, Wisconsin 54115 Phone: (920) 336-7700 | |
Prevea Health Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1601 Lawrence Dr, De Pere, Wisconsin 54115 Phone: (920) 496-4700 | |
Wal Mart Pharmacy 10-5090 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1415 Lawrence Dr, De Pere, Wisconsin 54115 Phone: (920) 336-7168 |